These rescue experiments, which aim to reverse the improvement in obesity-linked metabolic disorder by upregulating TAK1, reflect a requirement of TAK1 function in the development of obesity and inflammation states regulated by TRPM7. This evidence concerns the gene TRPM7 and metabolic disease.